ACTINIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 00507W956. A total of 3 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,045,865 | +29.3% | 1,921 | -10.4% | 1.79% | -10.1% |
| Q3 2022 | $1,582,000 | +86.6% | 2,143 | +21.5% | 2.00% | +245.9% |
| Q2 2022 | $848,000 | +12.8% | 1,764 | +19.9% | 0.58% | +415.2% |
| Q1 2022 | $752,000 | -68.7% | 1,471 | -63.2% | 0.11% | -68.0% |
| Q4 2021 | $2,405,000 | -27.8% | 4,001 | +6.5% | 0.35% | -22.2% |
| Q3 2021 | $3,329,000 | +4280.3% | 3,757 | +3657.0% | 0.45% | +2900.0% |
| Q1 2021 | $76,000 | -74.4% | 100 | -73.8% | 0.02% | -73.7% |
| Q4 2020 | $297,000 | – | 381 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 2,400 | $19,000 | 0.00% |
| SIMPLEX TRADING, LLC | 20,700 | $163,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |